About Homogentisate 1,2-dioxygenase
Homogentisate 1,2-dioxygenase (HGD) is a protein
from Homo sapiens identified by UniProt accession
Q93099, 445 residues long.
MolForge cross-references it against 0 known binders and
106 disease associations.
Target properties
| Protein name | Homogentisate 1,2-dioxygenase |
| UniProt accession | Q93099 |
| Gene | HGD |
| Organism | Homo sapiens |
| Length | 445 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (106)
Diseases linked to this target (Open Targets).
- alkaptonuria · score 0.85
- genetic disorder · score 0.19
- Barrett's esophagus · score 0.07
- pentosuria · score 0.07
- hyperdibasic aminoaciduria type 1 · score 0.07
- iminoglycinuria · score 0.07
- uridine-cytidineuria · score 0.06
- isolated sedoheptulokinase deficiency · score 0.06
- cystinuria · score 0.06
- seizures-intellectual disability due to hydroxylysinuria syndrome · score 0.06
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q93099-F1 | alphafold | PREDICTED | 96.78 | — |
Amino-acid sequence (445 residues)
MAELKYISGF GNECSSEDPR CPGSLPEGQN NPQVCPYNLY AEQLSGSAFT CPRSTNKRSW LYRILPSVSH KPFESIDEGQ VTHNWDEVDP DPNQLRWKPF EIPKASQKKV DFVSGLHTLC GAGDIKSNNG LAIHIFLCNT SMENRCFYNS DGDFLIVPQK GNLLIYTEFG KMLVQPNEIC VIQRGMRFSI DVFEETRGYI LEVYGVHFEL PDLGPIGANG LANPRDFLIP IAWYEDRQVP GGYTVINKYQ GKLFAAKQDV SPFNVVAWHG NYTPYKYNLK NFMVINSVAF DHADPSIFTV LTAKSVRPGV AIADFVIFPP RWGVADKTFR PPYYHRNCMS EFMGLIRGHY EAKQGGFLPG GGSLHSTMTP HGPDADCFEK ASKVKLAPER IADGTMAFMF ESSLSLAVTK WGLKASRCLD ENYHKCWEPL KSHFTPNSRN PAEPN
Explore Homogentisate 1,2-dioxygenase with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets